Stay updated with breaking news from Paul Mischel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cancer drug developer Boundless Bio is a pioneer in therapies that target extrachromosomal DNA. The IPO cash will support its pipeline, including a lead program on track to report preliminary data later this year.
The UK has some of the worst cancer survival rates in the developed world and death rates are set to rise - but its not all doom and gloom with positive breakthroughs also happening
Offering new hope for an alternative treatment of brain cancer, researchers have found that depriving the deadly tumour cells of cholesterol, which they import from neighbouring healthy cells, kills tumour cells.
Stanford Medicine brain cancer researchers joined other thought leaders in Washington, D.C. to discuss what the Biden Administration-led Cancer Moonshot initiative could mean.
Tiny circles of DNA that defy the accepted laws of genetics are key drivers of cancer formation, according to an international study led by researchers at Stanford Medicine.The circles, known as extrachromosomal DNA or ecDNA, often harbor cancer-asso